Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Rheumatology|April 1, 1990
Pharmacokinetics of auranofin a single dose study in manH P Benn, C Schnier, K U Seiler, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Tilidine does not affect human sphincter of Oddi motility--a randomized, controlled studyT Wehrmann, D Rausch, K U Seiler, et al.
Clinical Pharmacokinetics|March 1, 1980
The pharmacokinetics of metoprolol and its metabolites in dialysis patientsK U Seiler, K J Schuster, G J Meyer, et al.
Arzneimittel-Forschung|February 1, 1991
[Pharmacokinetics and pharmacodynamics of flunarizine in multimorbid, geriatric patients with vertigo]H P Rolzhäuser, W Oestreich, K U Seiler, et al.
Zeitschrift Fur Rheumatologie|January 1, 1991
[Biliary, renal and fecal elimination and distribution of gold after a single oral administration of auranofin, quantified by the instrumental neutron activation analysis method]H P Benn, C Schnier, E Bauer, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Prevention of an early re-occlusion after thrombolytic therapy of acute myocardial infarction by ketanserinS Brune, U Tebbe, T Schmidt, et al.
Journal of Clinical Pharmacology|April 1, 1993
Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserinD Trenk, K U Seiler, M Buschmann, et al.
The American Journal of Cardiology|April 1, 1989
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserinM Zehender, T Meinertz, S Hohnloser, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research GroupM Zehender, T Meinertz, S Hohnloser, et al.
Clinical Pharmacology and Therapeutics|December 1, 1991
Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysisU Gladziwa, R Bares, U Klotz, et al.
Pageof 2